Published in Am Heart J on May 01, 1974
Classical electrostatics in biology and chemistry. Science (1995) 17.26
Ankylosing spondylitis and HL-A 27. Lancet (1973) 11.99
Elective ventilation of potential organ donors. BMJ (1995) 5.50
Reiter's disease and HL-A 27. Lancet (1973) 4.10
Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int (1998) 4.03
Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV. J Med Genet (1992) 3.80
Reconciling the magnitude of the microscopic and macroscopic hydrophobic effects. Science (1991) 3.79
Physical activity, cystic erosions, and osteoporosis in rheumatoid arthritis. Ann Rheum Dis (1965) 3.62
Synovial cysts and rupture of the knee joint in rheumatoid arthritis. An arthrographic study. Ann Rheum Dis (1966) 3.09
Clinical survey of 354 patients with gout. Ann Rheum Dis (1970) 2.99
Acute anterior uveitis and HL-A 27. Lancet (1973) 2.74
Extracting hydrophobic free energies from experimental data: relationship to protein folding and theoretical models. Biochemistry (1991) 2.46
Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. J Biol Chem (1984) 2.25
Measurement of DNA antibodies by double antibody precipitation. Ann Rheum Dis (1973) 2.21
Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet (1990) 2.11
The clinical features and HLA associations of reactive arthritis associated with non-gonococcal urethritis. Q J Med (1979) 2.07
Role of Chlamydia trachomatis and HLA-B27 in sexually acquired reactive arthritis. Br Med J (1978) 2.01
Influence of trauma on the development of chronic inflammatory polyarthritis. Ann Rheum Dis (1967) 1.93
Cytogenetic and scanning study of patients receiving intra-articular injections of gold-198 and yttrium-90. Ann Rheum Dis (1973) 1.93
Six cases of gamma-D myelomatosis. Lancet (1966) 1.92
Allopurinol in treatment of gout. Br Med J (1966) 1.91
Free-energy determinants of alpha-helix insertion into lipid bilayers. Biophys J (1996) 1.89
Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J (1973) 1.88
Automated ligand placement and refinement with a combined force field and shape potential. Acta Crystallogr D Biol Crystallogr (2006) 1.84
HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet (1974) 1.68
Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68
Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis (1975) 1.67
Single daily dose of allopurinol. Ann Rheum Dis (1975) 1.66
Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis (1980) 1.65
The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen. J Biol Chem (1983) 1.52
Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health (2004) 1.48
Controlled inpatient study of tienilic acid in treatment of gout and hypertension. Ann Rheum Dis (1980) 1.46
Radioactive colloidal gold. In chronic knee effusions with Baker's cyst formation. Ann Rheum Dis (1970) 1.41
Uric acid excretion in the relatives of patients with gout. Ann Rheum Dis (1970) 1.37
Elucidation of new structures in lignins of CAD- and COMT-deficient plants by NMR. Phytochemistry (2001) 1.37
Microscopic studies on skeletal muscle in gout patients treated with allopurinol. Q J Med (1971) 1.34
Probenecid, nephrotic syndrome, and renal failure. Ann Rheum Dis (1968) 1.30
Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the pro alpha 2(I) collagen gene in a patient with osteogenesis imperfecta. Proc Natl Acad Sci U S A (1984) 1.29
Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J Clin Pharmacol (1996) 1.29
Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol (2000) 1.29
Organ donation. BMJ (1993) 1.27
Ethics and elective ventilation. Br J Hosp Med (1994) 1.25
A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man. Clin Sci (1968) 1.25
Effect of weight-loss on plasma and urinary levels of uric acid. Lancet (1972) 1.25
Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA. Postgrad Med J (1992) 1.23
Chronic monarticular synovitis. Diagnostic and prognostic features. Ann Rheum Dis (1975) 1.23
Plasma lipid levels in gout. Ann Rheum Dis (1972) 1.23
Withdrawal of allopurinol in patients with gout. Ann Rheum Dis (1974) 1.17
Studies on neutrophil function. 1. Physiological and pharmacological aspects. Br J Haematol (1966) 1.13
Long-term management of gout and hyperuricaemia. Br Med J (1980) 1.13
Clinical variability of osteogenesis imperfecta reflecting molecular heterogeneity: cysteine substitutions in the alpha 1(I) collagen chain producing lethal and mild forms. J Biol Chem (1986) 1.11
Serum uric acid in England and Scotland. Ann Rheum Dis (1977) 1.10
Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. Transplant Proc (1996) 1.05
Cardiac valvular disease in chronic inflammatory disorders of connective tissue. Factors influencing survival after surgery. Ann Rheum Dis (1975) 1.04
Fatal marrow aplasia in patient on penicillamine. Lancet (1976) 1.04
Proceedings: Complement activation in Reiter's syndrome. Ann Rheum Dis (1975) 1.03
Studies of uric acid pool size and turnover rate. Ann Rheum Dis (1969) 1.03
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
Staphylococcal septicaemia, endocarditis, and osteomyelitis in dialysis and renal transplant patients. Postgrad Med J (1980) 1.01
Factors inhibiting the excretion of uric acid. Proc R Soc Med (1966) 0.99
Drug-induced gout. Baillieres Clin Rheumatol (1991) 0.99
Ruptured abdominal aorta infected with Salmonella brandenburg. Br Med J (1968) 0.98
Frequency of chondrocalcinosis of the knees and avascular necrosis of the femoral heads in gout: a controlled study. Ann Rheum Dis (1980) 0.98
The Gaussian Generalized Born model: application to small molecules. Phys Chem Chem Phys (2007) 0.97
Career structure in rheumatology. Ann Rheum Dis (1969) 0.95
Uric acid clearance in patients with gout and normal subjects. Ann Rheum Dis (1971) 0.95
Nonarticular gout: hyperuricemia and tophus formation without gouty arthritis. Arthritis Rheum (1983) 0.94
Letter: Acute anterior uveitis and HL-A 27. Lancet (1974) 0.94
Multicentre trial of naproxen and phenylbutazone in acute gout. Ann Rheum Dis (1977) 0.94
Perceived numerosity as a function of item size. Percept Mot Skills (1988) 0.93
Circulating levels of biologically active parathyroid hormone in rheumatic diseases. Ann Rheum Dis (1982) 0.93
Family study of lipid and purine levels in gout patients. Ann Rheum Dis (1982) 0.93
Clinical and radiological features of osteonecrosis in systemic lupus erythematosus. Ann Rheum Dis (1979) 0.91
The arthropathy of the Muckle-Wells syndrome. Br J Rheumatol (1994) 0.90
Chlamydia trachomatis and infertility. Lancet (1986) 0.90
A review of stream nutrient criteria development in the United States. J Environ Qual (2013) 0.90
Food, drink, and gout. Br Med J (Clin Res Ed) (1983) 0.90
Rheumatoid synovitis and joint disease. Relationship between arthroscopic and histological changes. Ann Rheum Dis (1975) 0.90
Sulphobromophthalein retention in gout and asymptomatic hyperuricaemia. Ann Rheum Dis (1968) 0.90
Double-blind trial of feprazone and phenylbutazone in acute gout. Curr Med Res Opin (1980) 0.90
Plasma lipid levels and platelet adhesiveness in gout. Ann Rheum Dis (1971) 0.90
An arteriographic and histological study of digital arteries. Br J Radiol (1967) 0.88
Determinants of the first decade of bone loss after menopause at spine, hip and radius. QJM (1999) 0.88
Comparison of the growth of the Ehrlich ascites tumor in male and female mice. Cancer Res (1967) 0.87
Phenacetin, aspirin, and kidney damage. Am Heart J (1966) 0.87
Clinical and biochemical observations on three cases of hypoxanthine-guanine phosphoribosyltransferase deficiency. Ann Rheum Dis (1975) 0.87
Experience with silastic prostheses in rheumatoid hands. Ann Rheum Dis (1972) 0.87
Sexually acquired reactive arthritis. Ann Rheum Dis (1979) 0.87
Experience with Silastic prostheses in the rheumatoid hand. A 5-year follow-up. Ann Rheum Dis (1978) 0.86
Yersinia arthritis. Br Med J (1979) 0.86
Causes of hyperuricaemia. Proc R Soc Med (1969) 0.86
Chronic post-rheumatic fever (Jaccoud's) arthropathy. Ann Rheum Dis (1970) 0.85
Allopurinol interaction with cyclosporin. BMJ (1994) 0.85
Rat gastric acid secretion in response to graded subcutaneous doses of 2-deoxy-D-glucose. Am J Physiol (1966) 0.85
Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe. Immunol Lett (2003) 0.85
The interpretation of radioactive uric acid turnover data. Strahlentherapie Sonderb (1968) 0.85